Dong-A Socio Holdings Co., Ltd. (000640.KS)
KRW 110000.0
(4.86%)
KRW 110000.0
(4.86%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1957.1 Billion KRW | 13.03% |
| 2022 | 1731.45 Billion KRW | 2.37% |
| 2021 | 1691.38 Billion KRW | 11.93% |
| 2020 | 1511.1 Billion KRW | 11.23% |
| 2019 | 1358.57 Billion KRW | 9.39% |
| 2018 | 1241.93 Billion KRW | -14.9% |
| 2017 | 1459.44 Billion KRW | 4.08% |
| 2016 | 1402.21 Billion KRW | 14.61% |
| 2015 | 1223.51 Billion KRW | 13.18% |
| 2014 | 1081.06 Billion KRW | 9.39% |
| 2013 | 988.27 Billion KRW | -42.65% |
| 2012 | 1723.1 Billion KRW | 15.39% |
| 2011 | 1493.24 Billion KRW | 20.98% |
| 2010 | 1234.27 Billion KRW | 16.74% |
| 2009 | 1057.26 Billion KRW | 37.32% |
| 2008 | 769.94 Billion KRW | 7.88% |
| 2007 | 713.71 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2034.23 Billion KRW | 2.53% |
| 2024 Q1 | 1984.08 Billion KRW | 1.38% |
| 2023 FY | 1957.1 Billion KRW | 13.03% |
| 2023 Q2 | 1880.07 Billion KRW | 0.51% |
| 2023 Q1 | 1870.56 Billion KRW | 8.03% |
| 2023 Q3 | 1959.06 Billion KRW | 4.2% |
| 2023 Q4 | 1957.1 Billion KRW | -0.1% |
| 2022 Q4 | 1731.45 Billion KRW | -0.23% |
| 2022 FY | 1731.45 Billion KRW | 2.37% |
| 2022 Q3 | 1735.36 Billion KRW | 1.02% |
| 2022 Q2 | 1717.82 Billion KRW | 1.05% |
| 2022 Q1 | 1699.97 Billion KRW | 0.51% |
| 2021 Q4 | 1691.38 Billion KRW | -2.59% |
| 2021 FY | 1691.38 Billion KRW | 11.93% |
| 2021 Q3 | 1736.37 Billion KRW | 10.01% |
| 2021 Q2 | 1578.35 Billion KRW | 3.63% |
| 2021 Q1 | 1523.13 Billion KRW | 0.8% |
| 2020 Q3 | 1380.33 Billion KRW | 0.53% |
| 2020 Q1 | 1339.23 Billion KRW | -1.42% |
| 2020 Q2 | 1373.05 Billion KRW | 2.53% |
| 2020 Q4 | 1511.1 Billion KRW | 9.47% |
| 2020 FY | 1511.1 Billion KRW | 11.23% |
| 2019 Q3 | 1336.29 Billion KRW | -0.61% |
| 2019 Q4 | 1358.57 Billion KRW | 1.67% |
| 2019 Q2 | 1344.51 Billion KRW | 1.04% |
| 2019 Q1 | 1330.73 Billion KRW | 7.15% |
| 2019 FY | 1358.57 Billion KRW | 9.39% |
| 2018 Q4 | 1241.93 Billion KRW | -15.33% |
| 2018 FY | 1241.93 Billion KRW | -14.9% |
| 2018 Q2 | 1471.84 Billion KRW | 1.23% |
| 2018 Q1 | 1454.02 Billion KRW | -0.37% |
| 2018 Q3 | 1466.8 Billion KRW | -0.34% |
| 2017 Q4 | 1459.44 Billion KRW | -1.62% |
| 2017 Q3 | 1483.43 Billion KRW | -0.95% |
| 2017 Q2 | 1497.72 Billion KRW | -0.05% |
| 2017 FY | 1459.44 Billion KRW | 4.08% |
| 2017 Q1 | 1498.42 Billion KRW | 6.86% |
| 2016 FY | 1402.21 Billion KRW | 14.61% |
| 2016 Q2 | 1181.76 Billion KRW | -6.35% |
| 2016 Q3 | 1192.01 Billion KRW | 0.87% |
| 2016 Q4 | 1402.21 Billion KRW | 17.63% |
| 2016 Q1 | 1261.94 Billion KRW | 3.14% |
| 2015 Q4 | 1223.51 Billion KRW | -0.23% |
| 2015 Q3 | 1226.38 Billion KRW | 0.65% |
| 2015 FY | 1223.51 Billion KRW | 13.18% |
| 2015 Q1 | 1107.19 Billion KRW | 2.42% |
| 2015 Q2 | 1218.52 Billion KRW | 10.06% |
| 2014 Q3 | 1077.52 Billion KRW | 0.82% |
| 2014 FY | 1081.06 Billion KRW | 9.39% |
| 2014 Q4 | 1081.06 Billion KRW | 0.33% |
| 2014 Q2 | 1068.73 Billion KRW | 4.85% |
| 2014 Q1 | 1019.31 Billion KRW | 3.14% |
| 2013 Q2 | 878.38 Billion KRW | 4.58% |
| 2013 Q3 | 958.6 Billion KRW | 9.13% |
| 2013 FY | 988.27 Billion KRW | -42.65% |
| 2013 Q4 | 988.27 Billion KRW | 3.1% |
| 2013 Q1 | 839.89 Billion KRW | -51.26% |
| 2012 Q1 | 1268.06 Billion KRW | 0.0% |
| 2012 Q4 | 1723.1 Billion KRW | 0.0% |
| 2012 FY | 1723.1 Billion KRW | 15.39% |
| 2011 Q2 | 1155.83 Billion KRW | 1.13% |
| 2011 FY | 1493.24 Billion KRW | 20.98% |
| 2011 Q1 | 1142.95 Billion KRW | 0.0% |
| 2011 Q3 | 1200.32 Billion KRW | 3.85% |
| 2010 Q3 | 1174.97 Billion KRW | -1.11% |
| 2010 Q1 | 1025.75 Billion KRW | 0.0% |
| 2010 Q2 | 1188.22 Billion KRW | 15.84% |
| 2010 FY | 1234.27 Billion KRW | 16.74% |
| 2009 Q1 | 785.38 Billion KRW | 0.0% |
| 2009 Q2 | 793.52 Billion KRW | 1.04% |
| 2009 FY | 1057.26 Billion KRW | 37.32% |
| 2009 Q3 | 817.41 Billion KRW | 3.01% |
| 2008 Q3 | 729.44 Billion KRW | 5.13% |
| 2008 Q1 | 682.57 Billion KRW | 0.0% |
| 2008 Q2 | 693.83 Billion KRW | 1.65% |
| 2008 FY | 769.94 Billion KRW | 7.88% |
| 2007 Q1 | 625.46 Billion KRW | 0.0% |
| 2007 Q2 | 624.24 Billion KRW | -0.19% |
| 2007 Q3 | 715.82 Billion KRW | 14.67% |
| 2007 FY | 713.71 Billion KRW | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 198.21 Billion KRW | -887.373% |
| Ildong Holdings Co., Ltd. | 876.99 Billion KRW | -123.159% |
| HANDOK Inc. | 790.33 Billion KRW | -147.629% |
| Kukje Pharma Co., Ltd. | 170.61 Billion KRW | -1047.056% |
| Yuhan Corporation | 2814.07 Billion KRW | 30.453% |
| Dong-A ST Co., Ltd. | 1315.21 Billion KRW | -48.804% |
| SAMSUNG PHARM. Co., LTD. | 93.47 Billion KRW | -1993.631% |
| Hanmi Pharm. Co., Ltd. | 1952.03 Billion KRW | -0.26% |
| Hanall Biopharma Co.,Ltd | 239.74 Billion KRW | -716.322% |
| Ilyang Pharmaceutical Co.,Ltd | 468.9 Billion KRW | -317.38% |
| Dong Sung Bio Pharm.Co.,Ltd. | 114.97 Billion KRW | -1602.227% |
| MYUNGMOON Pharm co.,Ltd | 236.54 Billion KRW | -727.358% |
| Hana Pharm Co., Ltd. | 348.38 Billion KRW | -461.763% |
| Yuyu Pharma, Inc. | 198.21 Billion KRW | -887.373% |
| Ilsung Pharmaceuticals Co., Ltd. | 419.18 Billion KRW | -366.878% |
| REYON Pharmaceutical Co., Ltd. | 499.77 Billion KRW | -291.597% |
| Aprogen pharmaceuticals,Inc. | 589.39 Billion KRW | -232.052% |
| JW Holdings Corporation | 1176.26 Billion KRW | -66.383% |
| Ildong Pharmaceutical Co., Ltd. | 611.26 Billion KRW | -220.175% |
| Chong Kun Dang Pharmaceutical Corp. | 1402.42 Billion KRW | -39.551% |
| JW Pharmaceutical Corporation | 645.03 Billion KRW | -203.409% |
| Shin Poong Pharm.Co.,Ltd. | 350.08 Billion KRW | -459.04% |
| Hyundai Pharmaceutical Co., Ltd. | 154.04 Billion KRW | -1170.51% |
| Samil Pharmaceutical Co.,Ltd | 370.68 Billion KRW | -427.977% |
| Jeil Pharmaceutical Co.,Ltd | 487.32 Billion KRW | -301.601% |
| Yuyu Pharma, Inc. | 198.21 Billion KRW | -887.373% |
| Kwang Dong Pharmaceutical Co., Ltd. | 1078.06 Billion KRW | -81.539% |
| Daewoong pharmaceutical Co.,Ltd | 1770.31 Billion KRW | -10.552% |
| JW Pharmaceutical Corporation | 645.03 Billion KRW | -203.409% |
| Yuhan Corporation | 2814.07 Billion KRW | 30.453% |
| Jeil Pharma Holdings Inc | 879.99 Billion KRW | -122.399% |
| Yungjin Pharm. Co., Ltd. | 226.6 Billion KRW | -763.68% |
| Suheung Co., Ltd. | 993.73 Billion KRW | -96.944% |
| JW Pharmaceutical Corporation | 645.03 Billion KRW | -203.409% |
| Samjin Pharmaceuticals Co., Ltd. | 419.9 Billion KRW | -366.087% |
| Korea United Pharm Inc. | 468.86 Billion KRW | -317.418% |
| CKD Bio Corp. | 293.78 Billion KRW | -566.169% |
| Daewon Pharmaceutical Co., Ltd. | 507.99 Billion KRW | -285.258% |
| Dongwha Pharm.Co.,Ltd | 564.97 Billion KRW | -246.407% |
| Whan In Pharm Co.,Ltd. | 401.22 Billion KRW | -387.781% |
| Shin Poong Pharm.Co.,Ltd. | 350.08 Billion KRW | -459.04% |
| Chong Kun Dang Holdings Corp. | 1456 Billion KRW | -34.416% |
| Boryung Corporation | 922.36 Billion KRW | -112.184% |
| Bukwang Pharmaceutical Co., Ltd. | 442.46 Billion KRW | -342.322% |
| Ilyang Pharmaceutical Co.,Ltd | 468.9 Billion KRW | -317.38% |
| JW Lifescience Corporation | 255.83 Billion KRW | -664.984% |